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Abstract
Pathogens often inhabit the body asymptomatically, emerging to cause disease in response
to unknown triggers. In the bladder, latent intracellular Escherichia coli reservoirs are
regarded as likely origins of recurrent urinary tract infection (rUTI), a problem affecting mil-
lions of women worldwide. However, clinically plausible triggers that activate these reser-
voirs are unknown. Clinical studies suggest that the composition of a woman’s vaginal
microbiota influences her susceptibility to rUTI, but the mechanisms behind these associa-
tions are unclear. Several lines of evidence suggest that the urinary tract is routinely
exposed to vaginal bacteria, including Gardnerella vaginalis, a dominant member of the vag-
inal microbiota in some women. Using a mouse model, we show that bladder exposure to G.
vaginalis triggers E. coli egress from latent bladder reservoirs and enhances the potential
for life-threatening outcomes of the resulting E. coli rUTI. Transient G. vaginalis exposures
were sufficient to cause bladder epithelial apoptosis and exfoliation and interleukin-1-recep-
tor-mediated kidney injury, which persisted after G. vaginalis clearance from the urinary
tract. These results support a broader view of UTI pathogenesis in which disease can be
driven by short-lived but powerful urinary tract exposures to vaginal bacteria that are them-
selves not “uropathogenic” in the classic sense. This “covert pathogenesis” paradigm may
apply to other latent infections, (e.g., tuberculosis), or for diseases currently defined as non-
infectious because routine culture fails to detect microbes of recognized significance.
Author summary
Millions of women suffer from recurrent urinary tract infections (rUTI) and the only
treatment option is prophylactic antibiotics, which contributes to antibiotic resistance. In
experimental models, Escherichia coli, the dominant UTI pathogen, establishes reservoirs
inside the bladder lining; it is believed that some cases of rUTI in women may be due to
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these reservoirs awakening in response to triggers that are still unknown. Here we present
a new mouse model that demonstrates the first clinically plausible trigger of rUTI arising
from these reservoirs. Specifically, we show that bladder exposure to Gardnerella vaginalis,
a common member of the vaginal microbial community, can drive the emergence of E.
coli from bladder reservoirs. Furthermore, upon its exposure to the urinary tract, this vagi-
nal organism caused severe kidney damage and other complications, suggesting that car-
riage of particular vaginal bacteria could also impact a woman’s risk for kidney infection.
Bladder exposure to G. vaginalis is likely to occur during sexual activity in many women.
Taken together, these data provide the first explanation for why certain characteristics of
the vaginal microbiota have been linked with rUTI. Finally, our findings suggest that tar-
geting specific members of the vaginal community may be an effective strategy for treating
rUTI.
Introduction
Many disease-causing microorganisms can inhabit the human body asymptomatically, but fac-
tors that activate potentially pathogenic reservoirs to cause disease are not well understood.
After an initial infection, some pathogens establish states of latency that can reactivate to cause
recurrent symptomatic infections. In such cases, the problems lie not in diagnosing the recur-
rent infection, but rather in identifying and preventing potential triggers of reactivation and
predicting which patients are at risk for developing severe manifestations of disease. An
important example of bacterial latency and reactivation is bladder infection (cystitis), which
has the potential to develop into life-threatening kidney and systemic disease [1–4]. The blad-
der is one of the most common sites of infection in humans, and urinary tract infections
(UTIs) are one of the primary reasons for clinical use of antibiotics, accounting for 9% of all
antibiotic use in an ambulatory care setting [5,6]. UTIs also often recur; 25% of women
afflicted with acute UTI experience a recurrence within six months, and an estimated 1% of
women (70 million worldwide) suffer more than six recurrent UTIs (rUTIs) each year [6].
Infection is most often caused by uropathogenic E. coli, which can establish intracellular, anti-
biotic-resistant bladder reservoirs in mouse models [1–3,6,7]. In humans, episodes of rUTI are
often caused by the same strain of E. coli as the initial infection (~50% of cases according to
whole genome sequencing and up to 82% of cases by less stringent criteria) [8]. While rUTI
sometimes occurs due to reinfection of the bladder by E. coli residing in external sites (gastro-
intestinal tract, vagina), bladder intracellular E. coli reservoirs are regarded as another likely
source of rUTI in humans [2–4,8–10]. However, clinically plausible triggers of the transition
from latent bladder reservoirs to rUTI have not been identified.
Several lines of evidence implicate the vaginal microbiota in host susceptibility to bladder
and kidney infections. First, women with bacterial vaginosis (BV), a dysbiosis characterized by
overgrowth of fastidious anaerobes including Gardnerella vaginalis, are at higher risk of
experiencing UTI than women with normal vaginal communities (composed mainly of Lacto-
bacillus spp.) [11–14]. Second, women with rUTI experience fewer recurrences after vaginal
interventions that influence the microbiota, such as administration of Lactobacillus crispatus,
than do those receiving placebo [15,16]. Third, sexual activity is one of the strongest risk fac-
tors for both BV and UTI and is an independent risk factor for the development of ascending
kidney infection and pyelonephritis, a more serious form of UTI [6,16–22]. These clinical find-
ings support the longstanding idea that classic uropathogens gain access to the urinary tract by
mechanical transfer from nearby mucosal sites, such as the vagina.
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However, uropathogenic bacteria exist in mucosal sites within the context of the host
microbiota, not in isolation. Thus, bacteria other than classic uropathogens like E. coli are
likely to be frequently transferred from the vagina to the urinary tract. Consistent with this
idea, multiple studies have isolated bacterial species from urine (Gardnerella and lactobacilli
are among the most prominent) that are common members of the vaginal microbiota, sup-
porting the interpretation that the bladder is likely to be regularly exposed to vaginal bacteria
[23–26]. Therefore, we hypothesized that certain vaginal bacteria play an active role in the
bladder, potentially triggering E. coli emergence from bladder reservoirs to cause rUTI and
influencing the propensity for more serious forms of disease.
Results
G. vaginalis triggers E. coli rUTI
To test this hypothesis, we used an established model to generate mice with latent E. coli blad-
der reservoirs [2,27] and then investigated the effect of experimentally exposing the urinary
tract to vaginal bacteria. We chose Gardnerella vaginalis and Lactobacillus crispatus to repre-
sent ‘dysbiotic’ and ‘normal’ microbiotas, respectively, as these are often dominant members
of a woman’s vaginal microbiota [28,29]. Furthermore, we previously showed that G. vaginalis
is sufficient to elicit clinical features of BV in a mouse vaginal infection model [30]; thus, we
hypothesized that G. vaginalis may also contribute to the clinical association between BV and
rUTI by stimulating the emergence of latent E. coli reservoirs. To test this idea, we transureth-
rally infected mice with E. coli (primary infection) and monitored their urine for E. coli bacte-
rial titers for four weeks (Fig 1A). In C57BL/6 mice, failure to resolve urine titers after a month
is nearly always indicative of kidney infection; these animals were culled from the experiment.
Individuals with no detectable E. coli in urine at four weeks (~80% of those originally infected)
have been previously shown to contain latent E. coli reservoirs in bladder tissue [2] and were
used in subsequent experiments in which bladders were transurethrally exposed to vaginal
bacteria (G. vaginalis or L. crispatus) or vehicle alone (PBS). Mice were given two such expo-
sures one week apart, and we monitored the emergence of E. coli into urine every 24 hours for
72 hours after each exposure (Fig 1A, cream box).
Even though G. vaginalis failed to establish extended colonization of the urinary tract (Figs
1B and S1), its transient presence was sufficient to trigger E. coli emergence into urine (Fig 1C
and 1D). Although E. coli was sometimes detected in urine after one exposure to G. vaginalis,
the incidence was significantly higher after a second exposure (Figs 1C and S2), consistent
with clinical reports linking frequency of sexual activity with increased risk of UTI [19–21]. In
one experiment, two exposures with a 20-fold lower dose of G. vaginalis resulted in E. coli bac-
teriuria in 33% of mice, compared to 9% in a PBS control group (S3 Fig). Repeated G. vaginalis
exposures leading to E. coli emergence could be spaced as far apart as one week (Fig 1) or as
close as 12 hours (S3 Fig). In contrast, E. coli emergence was not induced by exposure to L. cris-
patus, which was cleared from the mouse urinary tract with similar kinetics to G. vaginalis,
(Fig 1B–1D) or exposure to heat-killed G. vaginalis (S3 Fig). Thus, reactivation of E. coli blad-
der lumen infection in this model was not simply a general response to bacterial exposure.
Rather, it was stimulated by a bacterium implicated in vaginal dysbiosis (G. vaginalis) [28,30]
but not by a bacterium widely recognized as beneficial (L. crispatus) [15,31]. Each of these
organisms commonly dominates the vaginal microbiota, supporting the physiological rele-
vance of the monomicrobial aspect of this model.
In support of the interpretation that E. coli emerged by egress from latent bladder reser-
voirs, the remaining E. coli titers in the bladder tissue at sacrifice were lower in G. vaginalis-
exposed mice than in those exposed to PBS or L. crispatus (Fig 1E). Finally, we found that
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mice in the G. vaginalis-exposed group that had high levels of E. coli bacteria in urine often
also had neutrophilic infiltrates (Fig 1F), confirming that emerging E. coli constituted active
rUTI. Perhaps not surprisingly, animals that went on to experience Gardnerella-induced
rUTI had more severe primary infections with E. coli compared to animals exposed to G.
vaginalis who did not experience rUTI (approximately 200-fold higher levels of E. coli in
urine at 24 hours after the initial E. coli infection) (S4 Fig). Moreover, those that did not expe-
rience rUTI included a significantly higher proportion (17% vs 2%, P = 0.02 by Fishers exact)
of individuals in whom E. coli bacteriuria during the initial infection was undetectable by 24
hours post infection (hpi). The lack of rUTI in these mice was not due simply to an absence
Fig 1. G. vaginalis bladder exposures induce E. coli emergence from latent bladder reservoirs. (A) Schematic of
mouse model. E. coli bladder reservoirs were established during a 4 week period following a ‘Primary E. coli UTI’; those
with kidney infections (bacteriuria at 4 weeks) were excluded; cream shading indicates period of exposure to G.
vaginalis, L. crispatus, or PBS; open circles, urine sample collections. (B) G. vaginalis and L. crispatus urine titers
following first exposure in mice with E. coli reservoirs. (C) Percentage of mice with detectable E. coli urine titers
following secondary exposures. N = 6 experiments totaling 155 mice. ** P < 0.001 by Fisher’s exact test. (D) Highest E.
coli urine titer from each mouse after exposure 2 (N = 6 independent experiments). Dotted line = limit of detection. A
Kruskal-Wallis test was performed (P < 0.0001), followed by post hoc pairwise comparisons. ****P < 0.0001;
**P < 0.002 by Mann-Whitney. (E) E. coli reservoir titers in bladder homogenates at 72 h after exposure 2 (N = 2).
**P < 0.01 by Mann-Whitney. (F) Example of Hema-3 stained urine sediments from a PBS-exposed mouse negative
for E. coli bacteriuria (left) and from a G. vaginalis-exposed mouse positive for E. coli bacteriuria (right). Arrows—
neutrophils.
doi:10.1371/journal.ppat.1006238.g001
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of E. coli bladder reservoirs, because many mice (in both the PBS and G. vaginalis exposure
groups) that cleared E. coli bacteriuria by 24 hpi still had detectable E. coli in bladder homoge-
nates. This finding suggests that the severity and/or duration of primary E. coli UTI may be a
key determinant of rUTI risk upon secondary exposure. Together, these results highlight G.
vaginalis as the first clinically plausible trigger capable of reactivating latent E. coli bladder
infection to cause rUTI.
G. vaginalis causes bladder epithelial exfoliation
Because chemical exfoliation of the bladder epithelium (urothelium) in mice containing latent
E. coli bladder reservoirs leads to the appearance of E. coli in urine [2,4], we wondered whether
exposure to G. vaginalis also results in apoptosis and exfoliation. Scanning electron microscopy
(SEM) analysis revealed that, whereas the bladder surface of PBS-exposed mice was smooth
and showed contiguous hexagonal superficial urothelial cells, G. vaginalis-exposed bladders
displayed patches of exfoliation and individual cells detached from their neighbors (Figs 2A
and S5). This occurred in 14/14 G. vaginalis exposed mice, both with and without latent E. coli
bladder reservoirs (Figs 2A and S5), but was not observed in 3 mice exposed to L. crispatus (S5
Fig). Further evidence of exfoliation comes from two additional lines of experimentation.
First, at 12 hours post-exposure, animals that received G. vaginalis exhibited reduced staining
for uroplakin IIIa, a marker of terminally differentiated superficial urothelial cells, compared
to PBS exposed animals (Fig 2B). Second, G. vaginalis-exposed mice had higher numbers of
urothelial cells in urine sediments than PBS-exposed mice (Fig 2C). Together with the estab-
lished relationship between urothelial exfoliation and E. coli emergence from bladder reser-
voirs [2,4], these data support the conclusion that G. vaginalis triggers E. coli rUTI by inducing
exfoliation (Fig 2D).
G. vaginalis induces apoptosis in the bladder epithelium
Previous studies have implicated programmed cell death in urothelial exfoliation [32] [9].
Consistent with apoptosis, we observed membrane protrusions [33] and blebbing in scanning
electron microscopy (SEM) images of all bladders exposed to G. vaginalis but in none of the
SEM images from mice exposed to PBS (Figs 3A and S6). G. vaginalis also caused membrane
protrusions and blebbing in mice that were not given a primary E. coli infection and thus had
no E. coli bladder reservoir (S6 Fig). In further support of the idea that G. vaginalis exposure
caused apoptosis, bladder epithelial cells from mice that were exposed to G. vaginalis were
TUNEL positive (Fig 3B) and displayed pronounced staining for cleaved caspase-3 (Figs 3C
and 3D and S7), both markers of apoptosis.
Consistent with apoptosis as an immunologically silent form of cell death, bladders of G.
vaginalis-exposed mice showed no increase in the levels of the pro-inflammatory cytokine IL-
1β (Figs 3E and S8), a marker of bladder epithelial exfoliation via pyroptosis [32]. In contrast,
levels of IL-12, IFN-γ, and RANTES were higher in the bladder upon exposure to G. vaginalis
than upon exposure to PBS (Figs 3E and S8). This cytokine signature is consistent with bladder
exfoliation, as these cytokines are also induced as a response to stripping of the bladder epithe-
lium by the immunotherapeutic agent Mycobacterium bovis bacillus Calmette-Guerin (BCG)
[34]. Together, these results demonstrate that bladder exposure to G. vaginalis results in apo-
ptosis of the urothelium. Evidence that this mechanism might also occur in humans comes
from clinical findings that bladder biopsies from women prone to rUTI exhibit more urothelial
apoptosis than do those from controls [35].
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G. vaginalis causes kidney inflammation and injury and predisposes to
severe E. coli infection
Reactivation of latent E. coli bladder infection has the potential to lead to a more severe mani-
festation of UTI: ascending infection of the kidneys (pyelonephritis), which can lead to urosep-
sis and death. Pyelonephritis often occurs in patients with associated risk factors such as
catheterization, urinary tract obstruction, or other anatomical abnormalities. However, in oth-
erwise healthy women, many of the identified risk factors of pyelonephritis overlap with BV
risk factors (e.g. sexual activity, new sex partner[s], lifetime number of sexual partners, oral
sex, spermicide use, smoking, and vaginal douching) [22,36]. Therefore, we used our model to
test the hypothesis that urinary tract exposures to G. vaginalis could influence the development
of kidney infection by E. coli. First, we detected G. vaginalis in 30–40% of kidneys at levels of
50–3000 cfu per kidney pair at three hours post-exposure both in mice with and without E. coli
reservoirs (Figs 4A and S1). G. vaginalis-exposed mice displayed higher levels of IL-1α, IL-1β,
TNF-α, MIP-1β, and IL-2 in the kidney (Fig 4B) and higher levels of serum creatinine, a bio-
marker of acute kidney injury [37], than PBS controls (Fig 4C). Finally, we examined the
Fig 2. G. vaginalis causes urothelial exfoliation. (A) Scanning electron micrographs of splayed bladders
showing the superficial hexagonal urothelial cells that line the bladder lumen. N = 2 independent experiments.
PBS, n = 3; G. vaginalis n = 7. ‘E’ denotes areas of exfoliation. (B) Immunofluorescence microscopy of
bladder sections. Red—uroplakin IIIa (superficial epithelial cells); Blue—DAPI. White lines—epithelial
basement membrane; L—bladder lumen. N = 3 independent experiments; n = 2–5 mice per group. (C)
Blinded scoring of urothelial cells in urine sediments collected between 3 and 24 h after two PBS or G.
vaginalis exposures. N = 3 independent experiments; PBS, n = 37; G. vaginalis, n = 59. * P = 0.0374 by
Fisher’s exact test. (D) Schematic model of G. vaginalis-induced recurrent E. coli UTI.
doi:10.1371/journal.ppat.1006238.g002
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relationship between kidney inflammation and injury, demonstrating that treatment of naïve
mice (no E. coli reservoirs) with an interleukin-1-receptor antagonist (anakinra) prior to and
during G. vaginalis exposure blocked kidney injury (Fig 4C). In summary, G. vaginalis was suf-
ficient to cause kidney damage independent of the presence of E. coli and this phenotype could
be blocked by an IL-1-receptor antagonist.
In addition to the inflammation and injury caused by G. vaginalis in the kidney (Fig 4B and
4C), exposure to the bacterium also rendered the kidney more susceptible to severe E. coli
infections. Approximately 6% (13/235) of G. vaginalis-exposed animals containing E. coli
Fig 3. G. vaginalis induces apoptosis in the urothelium. Data are from mice containing E. coli reservoirs
that were exposed twice (12 h apart) to G. vaginalis or PBS. Bladders were collected 3 h (A) or 12 h (B-E)
after the second exposure. (A) Scanning electron microscopy (SEM) images of bladders from mice exposed
to G. vaginalis. Top: G. vaginalis association with membrane protrusions. Bottom: membrane blebbing
consistent with apoptotic body formation. (B) TUNEL staining of bladder sections revealed TUNEL-positive
cells (white arrows) within the lumen (L) and superficial urothelium of G. vaginalis-exposed bladders. White
dotted line denotes the epithelial basement membrane. (C) Immunohistochemistry of bladder sections stained
for cleaved caspase-3 (brown). (D) Percentage of bladders in each exposure group that stained positively for
cleaved caspase-3. N = 2 independent experiments, 2–5 mice per group. (E) Level of pro-inflammatory
cytokines in bladder homogenates. A D’Agostino & Pearson omnibus normality test was performed followed
by appropriate pairwise analysis (either unpaired t-test or Mann-Whitney). * P < 0.05.
doi:10.1371/journal.ppat.1006238.g003
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reservoirs developed high titer E. coli kidney infection with severe abscesses and splenomegaly
(Fig 4D). This phenotype was extremely rare among reservoir-containing animals exposed to
PBS across all experiments we performed (1/214, ~0.5%), and was never seen in naïve mice
exposed only to G. vaginalis. The low incidence of abscesses in our model echoes the rarity of
pyelonephritis in women. Although only 1% of healthy reproductive-age women with cystitis
go on to experience pyelonephritis [6], one study showed that>9% of patients with G. vagina-
lis in urine had pyelonephritis [38]. As would be expected, pro-inflammatory cytokines/che-
mokines were present at even higher levels in an abscessed kidney collected at 72 h after
exposure (Fig 4B ‘X’ symbols). Analysis of spleens collected from a subset of mice with
abscessed kidneys revealed that both G. vaginalis and E. coli were capable of causing systemic
infection. In contrast, neither organism was detected in 20/20 spleens from mice lacking
abscesses and splenomegaly (P = 0.0119, Fisher’s exact). Notably, G. vaginalis has been found
in systemic infections in humans [39–42]. Our findings are also consistent with a clinical study
in which inpatients with G. vaginalis in urine were more likely to have a history of rUTI and
current kidney infection than patients without G. vaginalis in urine [38]. Taken together, our
Fig 4. G. vaginalis causes IL-1 receptor-mediated kidney injury and increases the incidence of severe E. coli kidney and systemic infection. (A-C)
Data are from mice that were exposed twice (12 h apart) to PBS or G. vaginalis as described in S3 Fig. (A) G. vaginalis titers in kidney tissue. (B) Cytokine/
chemokine levels in kidney homogenates at 12 h after the second exposure. Kruskal-Wallis tests were performed followed by post hoc pairwise comparison.
For comparison, data from an abscessed kidney collected at 72 h after exposure (not included in the statistical analysis) are denoted by symbols with a blue
‘X’. ** P < 0.005, * P < 0.05, Mann-Whitney (uncorrected P values). (C) Serum creatinine levels, a marker of acute kidney injury, at 12 h after the second
bladder exposure. Mice received 2 intraperitoneal injections of PBS (vehicle) or anakinra at ~16h prior to and at the time of transurethral inoculation. N = 6
independent experiments. ** P < 0.005, * P < 0.05. (D) Incidence of E. coli kidney infection with abscessed kidney and splenomegaly at 72 h post exposure.
Data are compiled from 12 experiments with two exposures (12 h and 1 wk apart, including mice injected with PBS as in C) and 1 experiment with 3
exposures, each 24 h apart. ** P = 0.0018, Fisher’s exact.
doi:10.1371/journal.ppat.1006238.g004
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results demonstrate that G. vaginalis exposure enhances E. coli urinary tract pathogenesis in
the mouse model; whether this also occurs in women warrants further investigation.
Discussion
Latent E. coli reservoirs are regarded as a source of rUTI, but until now, clinically relevant trig-
gers of reactivation have been unknown. Here, we used a new mouse model to show that tran-
sient exposures to G. vaginalis, a prevalent member of the vaginal microbiota and a dominant
species in women with BV, is sufficient to drive E. coli emergence from reservoirs and the
development of more serious manifestations of UTI, such as severe kidney infection (see
model in Fig 5). Our study both shows a direct role for the vaginal microbiota in UTI patho-
genesis and provides a mechanistic understanding of the cellular events leading to rUTI. We
identified a single bacterial species that may explain the long-standing but poorly understood
clinical association between BV and UTI. We note two possible translational outcomes of this
finding. First, our data suggest that therapies aimed at reducing G. vaginalis colonization of the
vagina could protect against E. coli rUTI. Second, given our finding that G. vaginalis exposures
cause kidney damage and increased the likelihood of kidney and systemic infections by E. coli
in mice, G. vaginalis colonization could be a risk factor for pyelonephritis in women. The pos-
sibility of preventing rUTI and subsequent pyelonephritis and systemic infection by targeting
G. vaginalis is an exciting concept given the alarming global rise in multi-drug resistant E. coli
[43].
Our model provides a new lens through which to view clinical findings relevant to the uri-
nary tract. For instance, it is widely thought that the strong relationship between sexual activity
and the risk of UTI [19–21] exists because E. coli or other classical uropathogens are trans-
ferred to the bladder from surrounding niches, such as the vagina. Our data suggest an alterna-
tive, albeit not mutually exclusive, model in which urinary tract exposure to certain members
of the vaginal microbiota, such as G. vaginalis, can elicit E. coli emergence from reservoirs
within the bladder. On this note, we emphasize that vaginal colonization with G. vaginalis can
occur in women who do not meet the diagnostic criteria for BV (for example, see the table of
strains and BV status in [44]). However, the finding that women with BV generally have high
vaginal burdens of G. vaginalis may make urinary tract exposure upon sexual activity (and the
potential consequences thereof) all the more likely. Previous reports that vaginal administra-
tion of L. crispatus reduces the incidence of subsequent rUTI have suggested that L. crispatus
may act by reducing the vaginal reservoir of E. coli [15]. In light of our data, we propose an
additional potential explanation for the protective effect of probiotic L. crispatus: the displace-
ment of G. vaginalis from the vagina, thereby reducing the likelihood of G. vaginalis-induced
recurrent E. coli UTI. Taken together, these observations suggest that repeated transient expo-
sures to G. vaginalis may be broadly important in determining susceptibility to E. coli rUTI
and may act through previously unrecognized routes.
Our results shed light on established, albeit largely ignored, clinical findings of G. vaginalis
in both the bladder and the kidney [45–51]. With respect to the bladder, our discovery that G.
vaginalis causes damage to the urothelium are relevant to a study in which 25% of women with
urinary frequency or dysuria had urine samples containing G. vaginalis in counts greater than
103 cfu/mL. Furthermore, G. vaginalis was isolated more frequently as a member of the “uri-
nary microbiome” of women suffering from urgency urinary incontinence (a.k.a. overactive
bladder syndrome) than healthy controls [23]. Although there is some debate regarding the
impact of “urinary microbiome” bacteria and whether or not they represent an established
community, our findings emphasize that long-standing colonization of the bladder may not be
required for bacteria such as G. vaginalis to affect disease outcomes. In regards to the kidney,
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our finding that G. vaginalis was associated with markers of kidney injury parallel a study in
which G. vaginalis was detected in urine collected directly from the bladder in 33% of patients
with “sterile pyelonephritis” (i.e., patients with reflux scarring in the apparent absence of bacte-
rial infection) [45]. Strikingly, G. vaginalis was localized to the upper urinary tract in 75% of
Fig 5. Model of Gardnerella vaginalis “covert pathogenesis.” In women, approximately half of recurrent
urinary tract infection (rUTI) episodes are caused by an E. coli strain identical to the strain that caused the
initial infection. Here we present a model of one mechanism of rUTI: activation of latent intracellular E. coli
reservoirs in the bladder. G. vaginalis urinary tract exposure, likely a consequence of sexual activity, results in
exfoliation of the bladder epithelium and damage to the kidney. Subsequent to exfoliation, E. coli emerges
from intracellular reservoirs into the bladder lumen, where it can ascend into the kidney, sometimes causing
severe inflammation and systemic infection. Often E. coli rUTI occurs after G. vaginalis clearance from the
urinary tract. These findings have important implications for our understanding of rUTI etiology and point to G.
vaginalis colonization as a potentially important marker of rUTI risk.
doi:10.1371/journal.ppat.1006238.g005
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these patients [45]. Despite these reports of G. vaginalis in the urinary tract, the classification
of G. vaginalis as a “uropathogen” is currently controversial. We note that fastidious growth
requirements make G. vaginalis unrecoverable, or at least unidentifiable, under conditions
most often used by clinical microbiology labs for the culture and identification of potential
uropathogens. Indeed, a recent investigation of 120 patient urines identified G. vaginalis by
proteomic analysis in nearly 20% of samples, none of which were classified as containing G.
vaginalis based on standard aerobic culture [52]. Thus, it is likely that the incidence of G. vagi-
nalis in the urinary tract is underestimated. Taken together with this body of clinical findings,
our data implicate G. vaginalis as a cause of urologic pathology, both together with and inde-
pendent of E. coli, and strongly support further investigations into the possible role of this
organism in urologic conditions of unknown or disputed etiology. Also of note, it is becoming
increasingly evident that there is a broad range of genetic and phenotypic diversity among
individual strains of G. vaginalis [53–55]. Future studies will reveal whether certain lineages of
G. vaginalis are more frequently associated with negative effects in the urinary tract.
Finally and more broadly, our work suggests a new paradigm for understanding and diag-
nosing recurrent infections. With few exceptions, the diagnosis and treatment of bacterial
infections is founded on the assumption that the pathogen present at the time of clinical pre-
sentation is the main driver of disease. However, this classical view of pathogenesis may be
overly simplistic. Our work provides a new paradigm we term “covert pathogenesis”, whereby
transient exposure to organism A triggers disease caused by organism B, despite organism A
being absent at the time of disease emergence. These short-lived bacterial exposures are likely
to be missed in the clinical setting because they occur before disease symptom onset but never-
theless could drive both the recurrence and severity of disease caused by a recognized patho-
gen. “Covert pathogenesis” may be relevant in other contexts in which the natural triggers of
disease have remained obscure. For instance, we see several striking parallels between our
model and another extremely common latent bacterial infection: tuberculosis (TB). Approxi-
mately one-third of the world’s population harbors latent TB in the lungs, with 5–15% devel-
oping symptomatic disease [56]. The recent reports of the “lung microbiome” [57,58] echo the
concept that the lung may be routinely transiently exposed to bacteria, and thus “covert patho-
genesis” should be explored as a potential mechanism of reactivation of latent TB. Ultimately,
our finding that short-lived microbial exposures influence disease pathogenesis may have far-
reaching implications beyond the urinary tract.
Materials and methods
Bacterial strains and growth conditions
Uropathogenic Escherichia coli clinical cystitis isolate UTI89 containing a kanamycin resis-
tance cassette (UTI89 kanR) [59] was grown static at 37˚C under aerobic conditions in Lysog-
eny broth (LB) medium or on LB agar plates supplemented with 25 μg/mL kanamycin. A
spontaneous streptomycin-resistant (SmR) strain of Gardnerella vaginalis derived from clinical
isolate JCP8151B (from a BV-positive woman) was cultured in NYCIII media or on NYCIII
agar plates supplemented with 1 mg/mL streptomycin at 37˚C in an anaerobic chamber. Lacto-
bacillus crispatus GED7756A was obtained from a vaginal swab of a BV-negative woman
(Nugent score = 1). The vaginal swab was transported from the clinic to the lab using Port-
A-Cu pre-reduced anaerobic transport media tubes (BD). Tubes were brought into a vinyl
anaerobic airlock chamber (Coy Products) under an atmosphere maintained at approximately
1% hydrogen and 0 ppm oxygen. Within 24 hours the swab was streaked to isolation using de
Man Rogosa and Sharpe (MRS) medium. All growth incubations were static at 37˚C, under
aerobic (E. coli) or anaerobic (G. vaginalis and L. crispatus) conditions, as we have previously
Transient microbiota exposures activate latent urinary tract infection
PLOS Pathogens | DOI:10.1371/journal.ppat.1006238 March 30, 2017 11 / 19
described [30,44,60,61]. For infection experiments, E. coli was inoculated from an LB agar
plate into 10 mL LB medium, grown ~24 h, then subcultured 1:10 in fresh LB for 18 h. E. coli
inoculum was prepared in phosphate buffered saline (PBS) at OD 0.35 (~1–2 x 107 colony
forming units (cfu) in 50 μL). G. vaginalis was inoculated from an NYCIII agar plate into 3 mL
NYCIII media and grown overnight, ~18 h. G. vaginalis inoculum was prepared in PBS at OD
5 (~5 x 107–1 x 108 cfu in 50 μL). L. crispatus was inoculated from an MRS agar plate into 3 mL
MRS media and grown overnight ~18 h. L. crispatus inoculum was prepared in PBS at OD 10
(~1 x 108 cfu in 50 μL). For experiments using heat-killed G. vaginalis, the inoculum was
divided into two aliquots and one was incubated at 80˚C for 10 min. Complete killing was con-
firmed by incubation on NYCII medium for 48 h anaerobically at 37˚C.
Ethics statement
Mouse experiments were carried out in strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals. The protocol was approved by the Animal
Studies Committee of Washington University School of Medicine (Protocol Number:
20140114).
Mice
Five- to six-week old female C57BL/6 mice were obtained from Charles River Labs (NCI
grantee order from Fredericks facility). Mice were given a regular chow diet in a specific patho-
gen-free facility at Washington University in St. Louis School of Medicine.
Mouse infection/exposure model
Mice (6–8 weeks of age) were anaesthetized with isofluorane and then inoculated transureth-
rally with 107 cfu E. coli (UTI89 kanR) in 50 μL sterile PBS as previously described [60,61].
Urine was collected and monitored for E. coli titers at 24 hours post infection (hpi) and weekly
for 4 weeks. Mice with E. coli bacteriuria (any level of bacteria in urine) at 4 wpi, thus pre-
sumed to have E. coli kidney infection based on previous reports [62] and our own observa-
tions, were culled from the experiments. Mice that were negative for bacteriuria, thus
presumed to contain intracellular E. coli reservoirs, were divided into groups for transurethral
exposure to either PBS, G. vaginalis (7x107- 1x108 JCP-8151B SmR) or L. crispatus (1x108
GED7756A). For individual experiments, 20 mice per group were required, to be powered
(0.8) to detect a statistically significant difference (p<0.05) between a 10% rate of spontaneous
rUTI in the control group and 50% rate of rUTI in the G. vaginalis group. The groups were fre-
quency matched based upon the time course of clearance of E. coli urine titers during the ini-
tial infection (also, E. coli titers at 24 hours post initial infection were not statistically different
between groups). Mice were inoculated transurethrally with PBS, G. vaginalis or L. crispatus
twice (12 h or 1 w apart). Urine was collected at 3, 6, 12, 24, 48 and 72 hpi (as indicated in text
and figure legends) and bacterial titers enumerated by serial dilution and plating on selective
media for either E. coli (LB+kanamycin) or G. vaginalis (NYCIII+streptomycin). Mice were
humanely sacrificed (cervical dislocation under isofluorane anaesthesia) to aseptically harvest
bladders, kidneys and spleens. Homogenates were prepared in 1 mL sterile PBS and plated on
appropriate selective media. Bacterial burden in each sample was calculated as cfu/bladder or
cfu/kidney pair. Samples with no colonies were plotted at one-half of the limit of detection. A
500 μL aliquot of each bladder and kidney homogenate was centrifuged at 13,000 rpm in a
benchtop microcentrifuge for 5 minutes at 4˚C and supernatants were removed and stored at
-20˚C for cytokine analysis, as described below.
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Urine sediment microscopy
Eighty microliters of a 10-fold dilution of urine was cytospun onto coated Cytopro Dual
microscope slides and stained with a Hema 3 staining kit (Fisher) to visualize epithelial cells
and neutrophils (PMNs). Slides were observed on a Olympus Vanox AHBT3 microscope.
Urine samples were scored qualitatively for the degree of epithelial exfoliation (ranging from
0 = none to 3 = robust) in a blinded fashion.
Scanning electron microscopy
Bladders were aseptically harvested, splayed, and fixed in EM fixative (2% paraformaldehyde,
2% glutaraldehyde in 0.1M sodium phosphate buffer, pH 7.4). Samples were prepared by criti-
cal point drying. Briefly, samples were post-fixed in 1.0% osmium tetroxide, dehydrated in
increasing concentrations of ethanol, then dehydrated at 31.1˚C and 1072 PSI for 16 minutes
in a critical point dryer. Samples were mounted on carbon tape-coated stubs and sputter-
coated with gold/palladium under argon. Bladders shown in Figs 2, 3 S5 and S6 were imaged
on a Zeiss Crossbeam 540 FIB-SEM. For preliminary analysis samples were imaged on a Hita-
chi S-2600H SEM. ImageJ 1.49v (National Institutes of Health, USA) was used to add scale
bars.
Immunofluorescence and immunohistochemistry
Bladders were fixed overnight in methacarn (60% methanol, 30% chloroform, 10% glacial ace-
tic acid) at room temperature followed by paraffin embedding and histological slide prepara-
tion performed by the Washington University School of Medicine Histology Core. For
immunofluorescence, slides were deparaffinized, hydrated, blocked with 1% BSA and 0.3% tri-
ton X-100 in PBS, incubated with primary antibody to uroplakin III (M-17 goat polyclonal
IgG, Santa Cruz Biotechnology) in blocking buffer overnight at 4˚C and secondary antibody
in PBS for 30–60 minutes at room temperature. Antibodies are verified at 1DegreeBio (http://
1degreebio.org/). Samples were stained with Hoechst for 5 min, mounted with ProLong Gold
anti-fade mounting medium (ThermoFisher / Life Technologies) and then visualized on an
Olympus BX61 fluorescent microscope using SlideBook 5.0 software. Terminal deoxynucleoti-
dyl transferase dUTP nick end labeling (TUNEL) staining was performed using the In situ Cell
Death Detection Kit (Roche) following manufacturer’s protocol for paraffin-embedded tissue.
Immunohistochemistry analysis of cleaved caspase-3 was performed using SignalStain Apo-
ptosis (Cleaved Caspase-3) IHC kit (Cell Signaling Technology) according to the manufac-
turer’s protocol.
Cytokine/chemokine analysis
Tissue homogenate supernatants collected as described above were thawed on ice, centrifuged
again at 4˚C to remove any remaining particulates and then cytokine expression was measured
using the Bio-Plex-Pro Mouse Cytokine 23-Plex Panel multiplex cytokine bead kit (Bio-Rad),
which quantifies 23 different cytokines/chemokines. Assay was performed according to manu-
facturer instructions, except using 10-fold less standard and half the amount of coupled beads
and detection antibodies indicated in the protocol.
Serum analysis of kidney damage
Blood was collected from mice at sacrifice by cardiac puncture and put into 400-μl Microtainer
serum separation tubes (BD). After coagulation, Microtainer tubes were subjected to centrifu-
gation at 15,000 × g for 5 min at room temperature and stored at −20˚C. Serum was thawed on
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ice and creatinine levels were measured using the QuantiChrom Creatinine Assay Kit (BioAs-
say Systems) according to manufacturers’ instructions.
Statistics
The figures show individual data with each data point from a different animal with a line at the
geometric mean or with box and whiskers (Min. to Max.) plots. The statistical tests used to
analyze each set of data are indicated in the figure legends. For non-parametric analyses, differ-
ences between the experimental groups were analyzed with a two-tailed unpaired Mann-
Whitney U test or Kruskal-Wallis test for comparisons of more than two groups using Prism
GraphPad software. For analysis of cytokines, raw uncorrected P values are provided.
Supporting information
S1 Fig. G. vaginalis is rapidly cleared from the mouse urinary tract. Graphs show titers of G.
vaginalis recovered from naïve mice not previously infected with E. coli (open symbols) or E.
coli reservoir-containing mice (closed symbols) in (A) urine (B) bladder homogenates and (C)
kidney homogenates at the indicated time points following a first or second bacterial exposure.
While it is unclear how G. vaginalis, which is non-motile, accesses the kidney, interestingly
there is precedent for non-motile bacteria accessing the kidney in C57BL/6 mice: Staphylococ-
cus saprophyticus [63], Enterococcus faecalis [64] and Group B Streptococcus (GBS) [65]. Thus,
this phenomenon is not limited to G. vaginalis and could be a shared feature of Gram positive
bacterial infection of the urinary tract. Data from 3 and 12 h after exposure 2 are also shown in
Fig 4A.  P< 0.05;  P< 0.01, Mann-Whitney. Dotted line = limit of detection.
(EPS)
S2 Fig. E. coli emergence into urine following exposure to G. vaginalis. Exposures 1 and 2
were 1 week apart, as indicated in Fig 1A. Dotted line = limit of detection. Samples with no
detectable bacteria are staggered below the limit of detection. N = 6 independent experiments.
(TIFF)
S3 Fig. Exposure to G. vaginalis triggers E. coli emergence from bladder reservoirs. (A) E.
coli emergence following PBS (n = 11) or G. vaginalis (n = 12) exposure. Experiment was per-
formed as outlined in Fig 1A, using 5 x 10 6 cfu G. vaginalis, a 20-fold lower dose than that
used in Fig 1. (B) Schematic of experiments shown in C-D, which were performed as outlined
in Fig 1A, except that the two G. vaginalis (or PBS control) exposures were given 12 h apart
(instead of 1 week). Additionally, two experiments included a group of mice exposed to heat-
killed G. vaginalis. (C) Percentage of mice with detectable E. coli urine titers post exposure
(N = 5 experiments totaling 184 mice).  P < 0.001 by Fisher’s exact test. (D) Highest E. coli
urine titers 24–72 h after 2 exposures. A Kruskal-Wallis test was performed (P = 0.002), fol-
lowed by post hoc pairwise comparisons.  P< 0.003,  P < 0.05 by Mann-Whitney. Dotted
line denotes the limit of detection.
(EPS)
S4 Fig. E. coli emergence from bladder reservoirs is more common in mice that experienced
high titer E. coli primary infection. E. coli titers at 24 hpi during the primary infection phase
(represented by the first open circle in Fig 1A). Data are from the same 6 independent experi-
ments depicted in Fig 1D and 1E. (A) Comparison of the E. coli infection level in mice that were
later exposed to either PBS or G. vaginalis (Fig 1A, green box). The distribution of initial (24 h
after inoculation) E. coli titers was not significantly different between the two groups prior to G.
vaginalis exposure. (B) The same data as shown in (A), except stratified based upon whether the
mouse experienced E. coli emergence into urine following G. vaginalis exposure. E. coli emergence
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from reservoirs was contingent upon initial 24 hpi E. coli urine titers>104 cfu/mL, Fisher’s exact
P = 0.0053. A Kruskal-Wallis test was performed, followed by post-hoc pairwise comparisons.
 P< 0.01, Mann-Whitney U test. In both panels the limit of detection was 100 cfu.
(EPS)
S5 Fig. G. vaginalis induces urothelial exfoliation independent of latent E. coli infection.
Scanning electron microscopy of splayed bladders from naïve (no E. coli reservoirs) (A) and E.
coli reservoir-containing (B) mice exposed twice (12 h apart) to PBS, G. vaginalis or L. crispa-
tus, as indicated, and harvested 3 hours after the second exposure. This phenotype of epithelial
exfoliation was observed in two independent experiments with mice containing E. coli reser-
voirs (7/7 G. vaginalis-exposed mice, 0/3 PBS-exposed mice, 0/2 L. crispatus-exposed mice)
and in three independent experiments with naive mice (7/7 G. vaginalis-exposed mice, 0/3
PBS-exposed mice, 0/1 L. crispatus-exposed mice). ‘E’ denotes areas of exfoliation.
(TIF)
S6 Fig. G. vaginalis exposure induces urothelial membrane protrusions and blebbing inde-
pendent of latent E. coli reservoirs. Scanning electron microscopy (SEM) of splayed bladders
from control mice exposed to PBS (A-C), or from naïve (no E. coli reservoirs) (D-F) and E.coli
reservoir-containing (G-O) mice exposed twice to G. vaginalis (12 h apart) and harvested 3
hours after the second exposure. Black arrows denote areas of membrane protrusions (~100
nm diameter) and blebbing. Panel M shows a red blood cell, seen in one bladder exposed to G.
vaginalis. Images are representative of two independent experiments with mice containing E.
coli reservoirs (phenotype was observed in 7/7 G. vaginalis-exposed mice and 0/3 PBS-exposed
mice) and three independent experiments with naive mice (phenotype was observed in 7/7 G.
vaginalis-exposed mice and 0/3 PBS-exposed mice).
(TIF)
S7 Fig. Immunohistochemistry for cleaved caspase-3 in bladder tissue sections. Additional
images from experiments described in Fig 2C. Top box: bladders from naïve mice (no E. coli res-
ervoirs). Bottom box: bladders from mice containing E. coli reservoirs. Images within each dot-
ted line box are from bladder sections that were on the same slide. Scale bars are 20 μm, with the
exception of the top row of images from E. coli reservoir-containing bladder are low magnifica-
tion (scale bar 100 μm), with white dotted boxes denoting the area at higher magnification in the
image directly below. Box in the bottom right corner shows the number of mice in each group
that were either (-) or (+) for cleaved caspase-3 staining based on blinded scoring, as described
in Materials and Methods. These values were used to generate the graph shown in Fig 2D.
(TIF)
S8 Fig. Cytokine/Chemokine analysis of bladder tissue. Naive mice (open symbols) or E. coli
reservoir-containing mice (closed symbols) exposed to either PBS (circles) or G. vaginalis
(squares). A Kruskal-Wallis test detected significant difference between the groups for
RANTES, IL-12 and IFN-γ. A D’Agostino-Pearson omnibus normality test was performed, fol-
lowed by appropriate post-hoc pairwise analysis (either unpaired t-test or Mann-Whitney U
test).  P = 0.01;  P< 0.05. Unless otherwise depicted with a line, P values represent statisti-
cally significant differences from naive mice exposed to PBS (open circles).
(TIFF)
Acknowledgments
We thank Francisca Chou, Nadum Member-Meneh and Lynne Foster for technical assistance,
Deborah J. Frank, Karen Dodson, Stephen Beverley, David Sibley, and Scott Hultgren for
Transient microbiota exposures activate latent urinary tract infection
PLOS Pathogens | DOI:10.1371/journal.ppat.1006238 March 30, 2017 15 / 19
critical reading of the manuscript, Jaclynn Lett, Matthew Joens and James Fitzpatrick for assis-
tance with SEM analysis, Jennifer Lodge for use of her microscope and Scott Hultgren for the
clinical E. coli isolate UTI89 and anti-uroplakin antibodies.
Author Contributions
Conceptualization: NMG VPO ALL.
Data curation: NMG.
Formal analysis: NMG ALL.
Funding acquisition: NMG ALL.
Investigation: NMG VPO.
Methodology: NMG VPO ALL.
Project administration: ALL.
Resources: ALL.
Visualization: NMG VPO ALL.
Writing – original draft: NMG.
Writing – review & editing: NMG VPO ALL.
References
1. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ (2015) Urinary tract infections: epidemiology,
mechanisms of infection and treatment options. Nat Rev Microbiol 13: 269–284. doi: 10.1038/
nrmicro3432 PMID: 25853778
2. Mysorekar IU, Hultgren SJ (2006) Mechanisms of uropathogenic Escherichia coli persistence and erad-
ication from the urinary tract. Proc Natl Acad Sci U S A 103: 14170–14175. doi: 10.1073/pnas.
0602136103 PMID: 16968784
3. Hooton TM (2012) Clinical practice. Uncomplicated urinary tract infection. N Engl J Med 366: 1028–
1037. doi: 10.1056/NEJMcp1104429 PMID: 22417256
4. Blango MG, Ott EM, Erman A, Veranic P, Mulvey MA (2014) Forced resurgence and targeting of intra-
cellular uropathogenic Escherichia coli reservoirs. PLoS One 9: e93327. doi: 10.1371/journal.pone.
0093327 PMID: 24667805
5. Shapiro DJ, Hicks LA, Pavia AT, Hersh AL (2014) Antibiotic prescribing for adults in ambulatory care in
the USA, 2007–09. J Antimicrob Chemother 69: 234–240. doi: 10.1093/jac/dkt301 PMID: 23887867
6. Foxman B (2014) Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors,
and disease burden. Infect Dis Clin North Am 28: 1–13. doi: 10.1016/j.idc.2013.09.003 PMID:
24484571
7. Kerrn MB, Struve C, Blom J, Frimodt-Moller N, Krogfelt KA (2005) Intracellular persistence of Escheri-
chia coli in urinary bladders from mecillinam-treated mice. J Antimicrob Chemother 55: 383–386. doi:
10.1093/jac/dki002 PMID: 15681580
8. Silverman JA, Schreiber HLT, Hooton TM, Hultgren SJ (2013) From physiology to pharmacy: develop-
ments in the pathogenesis and treatment of recurrent urinary tract infections. Curr Urol Rep 14: 448–
456. doi: 10.1007/s11934-013-0354-5 PMID: 23832844
9. Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, et al. (1998) Induction and evasion of
host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282: 1494–1497. PMID:
9822381
10. Erman A, Krizan Hergouth V, Blango MG, Kerec Kos M, Mulvey MA, et al. (2017) Repeated treatments
with chitosan in combination with antibiotics completely eradicate uropathogenic Escherichia coli from
infected mouse urinary bladders. J Infect Dis.
11. Sumati AH, Saritha NK (2009) Association of urinary tract infection in women with bacterial vaginosis. J
Glob Infect Dis 1: 151–152. doi: 10.4103/0974-777X.56254 PMID: 20300409
Transient microbiota exposures activate latent urinary tract infection
PLOS Pathogens | DOI:10.1371/journal.ppat.1006238 March 30, 2017 16 / 19
12. Hillebrand L, Harmanli OH, Whiteman V, Khandelwal M (2002) Urinary tract infections in pregnant
women with bacterial vaginosis. Am J Obstet Gynecol 186: 916–917. PMID: 12015512
13. Harmanli OH, Cheng GY, Nyirjesy P, Chatwani A, Gaughan JP (2000) Urinary tract infections in women
with bacterial vaginosis. Obstet Gynecol 95: 710–712. PMID: 10775734
14. Hooton TM, Fihn SD, Johnson C, Roberts PL, Stamm WE (1989) Association between bacterial vagino-
sis and acute cystitis in women using diaphragms. Arch Intern Med 149: 1932–1936. PMID: 2673116
15. Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, et al. (2011) Randomized, placebo-
controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recur-
rent urinary tract infection. Clin Infect Dis 52: 1212–1217. doi: 10.1093/cid/cir183 PMID: 21498386
16. Raz R, Stamm WE (1993) A controlled trial of intravaginal estriol in postmenopausal women with recur-
rent urinary tract infections. N Engl J Med 329: 753–756. doi: 10.1056/NEJM199309093291102 PMID:
8350884
17. Nicolle LE, Harding GK, Preiksaitis J, Ronald AR (1982) The association of urinary tract infection with
sexual intercourse. J Infect Dis 146: 579–583. PMID: 7130747
18. Stapleton A, Latham RH, Johnson C, Stamm WE (1990) Postcoital antimicrobial prophylaxis for recur-
rent urinary tract infection. A randomized, double-blind, placebo-controlled trial. JAMA 264: 703–706.
PMID: 2197450
19. Stamatiou C, Bovis C, Panagopoulos P, Petrakos G, Economou A, et al. (2005) Sex-induced cystitis—
patient burden and other epidemiological features. Clin Exp Obstet Gynecol 32: 180–182. PMID:
16433159
20. Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, et al. (1996) A prospective study of risk fac-
tors for symptomatic urinary tract infection in young women. N Engl J Med 335: 468–474. doi: 10.1056/
NEJM199608153350703 PMID: 8672152
21. Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, et al. (2000) Risk factors for recurrent uri-
nary tract infection in young women. J Infect Dis 182: 1177–1182. doi: 10.1086/315827 PMID:
10979915
22. Bautista CT, Wurapa E, Sateren WB, Morris S, Hollingsworth B, et al. (2016) Bacterial vaginosis: a syn-
thesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonor-
rhea infections. Mil Med Res 3: 4. doi: 10.1186/s40779-016-0074-5 PMID: 26877884
23. Pearce MM, Hilt EE, Rosenfeld AB, Zilliox MJ, Thomas-White K, et al. (2014) The female urinary micro-
biome: a comparison of women with and without urgency urinary incontinence. MBio 5: e01283–01214.
doi: 10.1128/mBio.01283-14 PMID: 25006228
24. Pearce MM, Zilliox MJ, Rosenfeld AB, Thomas-White KJ, Richter HE, et al. (2015) The female urinary
microbiome in urgency urinary incontinence. Am J Obstet Gynecol 213: 347 e341–311.
25. Hilt EE, McKinley K, Pearce MM, Rosenfeld AB, Zilliox MJ, et al. (2014) Urine is not sterile: use of
enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin
Microbiol 52: 871–876. doi: 10.1128/JCM.02876-13 PMID: 24371246
26. Whiteside SA, Razvi H, Dave S, Reid G, Burton JP (2015) The microbiome of the urinary tract—a role
beyond infection. Nat Rev Urol 12: 81–90. doi: 10.1038/nrurol.2014.361 PMID: 25600098
27. Mulvey MA, Schilling JD, Hultgren SJ (2001) Establishment of a persistent Escherichia coli reservoir
during the acute phase of a bladder infection. Infect Immun 69: 4572–4579. doi: 10.1128/IAI.69.7.
4572-4579.2001 PMID: 11402001
28. Gardner HL, Dukes CD (1954) New etiologic agent in nonspecific bacterial vaginitis. Science 120: 853.
29. Ma B, Forney LJ, Ravel J (2012) Vaginal microbiome: rethinking health and disease. Annu Rev Micro-
biol 66: 371–389. doi: 10.1146/annurev-micro-092611-150157 PMID: 22746335
30. Gilbert NM, Lewis WG, Lewis AL (2013) Clinical features of bacterial vaginosis in a murine model of
vaginal infection with Gardnerella vaginalis. PLoS One 8: e59539. doi: 10.1371/journal.pone.0059539
PMID: 23527214
31. Petrova MI, Lievens E, Malik S, Imholz N, Lebeer S (2015) Lactobacillus species as biomarkers and
agents that can promote various aspects of vaginal health. Front Physiol 6: 81. doi: 10.3389/fphys.
2015.00081 PMID: 25859220
32. Nagamatsu K, Hannan TJ, Guest RL, Kostakioti M, Hadjifrangiskou M, et al. (2015) Dysregulation of
Escherichia coli alpha-hemolysin expression alters the course of acute and persistent urinary tract infec-
tion. Proc Natl Acad Sci U S A 112: E871–880. doi: 10.1073/pnas.1500374112 PMID: 25675528
33. Atkin-Smith GK, Tixeira R, Paone S, Mathivanan S, Collins C, et al. (2015) A novel mechanism of gen-
erating extracellular vesicles during apoptosis via a beads-on-a-string membrane structure. Nat Com-
mun 6: 7439. doi: 10.1038/ncomms8439 PMID: 26074490
Transient microbiota exposures activate latent urinary tract infection
PLOS Pathogens | DOI:10.1371/journal.ppat.1006238 March 30, 2017 17 / 19
34. Redelman-Sidi G, Glickman MS, Bochner BH (2014) The mechanism of action of BCG therapy for blad-
der cancer—a current perspective. Nat Rev Urol 11: 153–162. doi: 10.1038/nrurol.2014.15 PMID:
24492433
35. Chuang FC, Kuo HC (2013) Increased urothelial cell apoptosis and chronic inflammation are associated
with recurrent urinary tract infection in women. PLoS One 8: e63760. doi: 10.1371/journal.pone.
0063760 PMID: 23691091
36. Scholes D, Hooton TM, Roberts PL, Gupta K, Stapleton AE, et al. (2005) Risk factors associated with
acute pyelonephritis in healthy women. Ann Intern Med 142: 20–27. PMID: 15630106
37. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, et al. (2004) Acute renal failure—definition, out-
come measures, animal models, fluid therapy and information technology needs: the Second Interna-
tional Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8: R204–
212. doi: 10.1186/cc2872 PMID: 15312219
38. Josephson S, Thomason J, Sturino K, Zabransky R, Williams J (1988) Gardnerella vaginalis in the uri-
nary tract: incidence and significance in a hospital population. Obstet Gynecol 71: 245–250. PMID:
3257296
39. Lagace-Wiens PR, Ng B, Reimer A, Burdz T, Wiebe D, et al. (2008) Gardnerella vaginalis bacteremia in
a previously healthy man: case report and characterization of the isolate. J Clin Microbiol 46: 804–806.
doi: 10.1128/JCM.01545-07 PMID: 18057138
40. McCool RA, DeDonato DM (2012) Bacteremia of Gardnerella vaginalis after endometrial ablation. Arch
Gynecol Obstet 286: 1337–1338. doi: 10.1007/s00404-012-2447-7 PMID: 22752597
41. Yoon HJ, Chun J, Kim JH, Kang SS, Na DJ (2010) Gardnerella vaginalis septicaemia with pyelonephri-
tis, infective endocarditis and septic emboli in the kidney and brain of an adult male. Int J STD AIDS 21:
653–657. doi: 10.1258/ijsa.2010.009574 PMID: 21097741
42. Agostini A, Beerli M, Franchi F, Bretelle F, Blanc B (2003) Garnerella vaginalis bacteremia after vaginal
myomectomy. Eur J Obstet Gynecol Reprod Biol 108: 229. PMID: 12781418
43. Organization WH (2014) Antimicrobial resistance: global report on surveillance 2014. 257 p.
44. Lewis WG, Robinson LS, Gilbert NM, Perry JC, Lewis AL (2013) Degradation, foraging, and depletion
of mucus sialoglycans by the vagina-adapted Actinobacterium Gardnerella vaginalis. J Biol Chem 288:
12067–12079. doi: 10.1074/jbc.M113.453654 PMID: 23479734
45. Fairley KF, Birch DF (1983) Unconventional bacteria in urinary tract disease: Gardnerella vaginalis. Kid-
ney Int 23: 862–865. PMID: 6604191
46. Birch DF, D’Apice AJ, Fairley KF (1981) Ureaplasma urealyticum in the upper urinary tracts of renal allo-
graft recipients. J Infect Dis 144: 123–127. PMID: 7024429
47. McDonald MI, Lam MH, Birch DF, D’Arcy AF, Fairley KF, et al. (1982) Ureaplasma urealyticum in
patients with acute symptoms of urinary tract infection. J Urol 128: 517–519. PMID: 6981712
48. McDowall DR, Buchanan JD, Fairley KF, Gilbert GL (1981) Anaerobic and other fastidious microorgan-
isms in asymptomatic bacteriuria in pregnant women. J Infect Dis 144: 114–122. PMID: 7276624
49. McFadyen IR, Eykyn SJ (1968) Suprapubic aspiration of urine in pregnancy. Lancet 1: 1112–1114.
PMID: 4171842
50. Savige JA, Birch DF, Fairley KF (1983) Comparison of mid catheter collection and suprapubic aspiration
of urine for diagnosing bacteriuria due to fastidious micro-organisms. J Urol 129: 62–63. PMID:
6338252
51. Johnson AP, Boustouller YL (1987) Extra-vaginal infection caused by Gardnerella vaginalis. Epidemiol
Infect 98: 131–137. PMID: 3493915
52. Yu Y, Sikorski P, Bowman-Gholston C, Cacciabeve N, Nelson KE, et al. (2015) Diagnosing inflamma-
tion and infection in the urinary system via proteomics. J Transl Med 13: 111. doi: 10.1186/s12967-015-
0475-3 PMID: 25889401
53. Ahmed A, Earl J, Retchless A, Hillier SL, Rabe LK, et al. (2012) Comparative genomic analyses of 17
clinical isolates of Gardnerella vaginalis provide evidence of multiple genetically isolated clades consis-
tent with subspeciation into genovars. J Bacteriol 194: 3922–3937. doi: 10.1128/JB.00056-12 PMID:
22609915
54. Santiago GL, Deschaght P, El Aila N, Kiama TN, Verstraelen H, et al. (2011) Gardnerella vaginalis com-
prises three distinct genotypes of which only two produce sialidase. Am J Obstet Gynecol 204: 450
e451–457.
55. Pleckaityte M, Janulaitiene M, Lasickiene R, Zvirbliene A (2012) Genetic and biochemical diversity of
Gardnerella vaginalis strains isolated from women with bacterial vaginosis. FEMS Immunol Med Micro-
biol 65: 69–77. doi: 10.1111/j.1574-695X.2012.00940.x PMID: 22309200
Transient microbiota exposures activate latent urinary tract infection
PLOS Pathogens | DOI:10.1371/journal.ppat.1006238 March 30, 2017 18 / 19
56. Getahun H, Chaisson RE, Raviglione M (2015) Latent Mycobacterium tuberculosis Infection. N Engl J
Med 373: 1179–1180.
57. O’Dwyer DN, Dickson RP, Moore BB (2016) The Lung Microbiome, Immunity, and the Pathogenesis of
Chronic Lung Disease. J Immunol 196: 4839–4847. doi: 10.4049/jimmunol.1600279 PMID: 27260767
58. Dickson RP, Huffnagle GB (2015) The Lung Microbiome: New Principles for Respiratory Bacteriology in
Health and Disease. PLoS Pathog 11: e1004923. doi: 10.1371/journal.ppat.1004923 PMID: 26158874
59. Wright KJ, Seed PC, Hultgren SJ (2005) Uropathogenic Escherichia coli flagella aid in efficient urinary
tract colonization. Infect Immun 73: 7657–7668. doi: 10.1128/IAI.73.11.7657-7668.2005 PMID:
16239570
60. Kline KA, Schwartz DJ, Gilbert NM, Lewis AL (2014) Impact of host age and parity on susceptibility to
severe urinary tract infection in a murine model. PLoS One 9: e97798. doi: 10.1371/journal.pone.
0097798 PMID: 24835885
61. Kline KA, Schwartz DJ, Gilbert NM, Hultgren SJ, Lewis AL (2012) Immune modulation by group B Strep-
tococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli. Infect
Immun 80: 4186–4194. doi: 10.1128/IAI.00684-12 PMID: 22988014
62. Hannan TJ, Mysorekar IU, Hung CS, Isaacson-Schmid ML, Hultgren SJ (2010) Early severe inflamma-
tory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS
Pathog 6: e1001042. doi: 10.1371/journal.ppat.1001042 PMID: 20811584
63. Kline KA, Ingersoll MA, Nielsen HV, Sakinc T, Henriques-Normark B, et al. (2010) Characterization of a
novel murine model of Staphylococcus saprophyticus urinary tract infection reveals roles for Ssp and
SdrI in virulence. Infect Immun 78: 1943–1951. doi: 10.1128/IAI.01235-09 PMID: 20176795
64. Guiton PS, Hung CS, Hancock LE, Caparon MG, Hultgren SJ (2010) Enterococcal biofilm formation
and virulence in an optimized murine model of foreign body-associated urinary tract infections. Infect
Immun 78: 4166–4175. doi: 10.1128/IAI.00711-10 PMID: 20696830
65. Kulkarni R, Randis TM, Antala S, Wang A, Amaral FE, et al. (2013) beta-Hemolysin/cytolysin of Group
B Streptococcus enhances host inflammation but is dispensable for establishment of urinary tract infec-
tion. PLoS One 8: e59091. doi: 10.1371/journal.pone.0059091 PMID: 23505569
Transient microbiota exposures activate latent urinary tract infection
PLOS Pathogens | DOI:10.1371/journal.ppat.1006238 March 30, 2017 19 / 19
